Scott E. Counts, Ph.D. - Publications

Emory University, Atlanta, GA 

53 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2016 Mufson EJ, Ikonomovic MD, Counts SE, Perez SE, Malek-Ahmadi M, Scheff SW, Ginsberg SD. Molecular and Cellular Pathophysiology of Preclinical Alzheimer's Disease. Behavioural Brain Research. PMID 27185734 DOI: 10.1016/j.bbr.2016.05.030  0.8
2016 Tiernan CT, Ginsberg SD, Guillozet-Bongaarts AL, Ward SM, He B, Kanaan NM, Mufson EJ, Binder LI, Counts SE. Protein homeostasis gene dysregulation in pretangle-bearing nucleus basalis neurons during the progression of Alzheimer's disease. Neurobiology of Aging. 42: 80-90. PMID 27143424 DOI: 10.1016/j.neurobiolaging.2016.02.031  0.8
2015 Weinberg RB, Mufson EJ, Counts SE. Evidence for a neuroprotective microRNA pathway in amnestic mild cognitive impairment. Frontiers in Neuroscience. 9: 430. PMID 26594146 DOI: 10.3389/fnins.2015.00430  0.8
2015 Mufson EJ, Mahady L, Waters D, Counts SE, Perez SE, DeKosky ST, Ginsberg SD, Ikonomovic MD, Scheff SW, Binder LI. Hippocampal plasticity during the progression of Alzheimer's disease. Neuroscience. PMID 25772787 DOI: 10.1016/j.neuroscience.2015.03.006  0.8
2014 Counts SE, Perez SE, He B, Mufson EJ. Intravenous immunoglobulin reduces tau pathology and preserves neuroplastic gene expression in the 3xTg mouse model of Alzheimer's disease. Current Alzheimer Research. 11: 655-63. PMID 25156574  0.8
2014 Counts SE, Lahiri DK. Overview of immunotherapy in Alzheimer's disease (AD) and mechanisms of IVIG neuroprotection in preclinical models of AD. Current Alzheimer Research. 11: 623-5. PMID 25156573 DOI: 10.2174/156720501107140815102453  0.8
2014 Counts SE, Ray B, Mufson EJ, Perez SE, He B, Lahiri DK. Intravenous immunoglobulin (IVIG) treatment exerts antioxidant and neuropreservatory effects in preclinical models of Alzheimer's disease. Journal of Clinical Immunology. 34: S80-5. PMID 24760109 DOI: 10.1007/s10875-014-0020-9  0.8
2014 Counts SE, Alldred MJ, Che S, Ginsberg SD, Mufson EJ. Synaptic gene dysregulation within hippocampal CA1 pyramidal neurons in mild cognitive impairment. Neuropharmacology. 79: 172-9. PMID 24445080 DOI: 10.1016/j.neuropharm.2013.10.018  0.8
2013 Fonseca MI, McGuire SO, Counts SE, Tenner AJ. Complement activation fragment C5a receptors, CD88 and C5L2, are associated with neurofibrillary pathology. Journal of Neuroinflammation. 10: 25. PMID 23394121 DOI: 10.1186/1742-2094-10-25  0.8
2012 Mufson EJ, He B, Nadeem M, Perez SE, Counts SE, Leurgans S, Fritz J, Lah J, Ginsberg SD, Wuu J, Scheff SW. Hippocampal proNGF signaling pathways and β-amyloid levels in mild cognitive impairment and Alzheimer disease. Journal of Neuropathology and Experimental Neurology. 71: 1018-29. PMID 23095849 DOI: 10.1097/NEN.0b013e318272caab  0.8
2012 Perez SE, Nadeem M, Sadleir KR, Matras J, Kelley CM, Counts SE, Vassar R, Mufson EJ. Dimebon alters hippocampal amyloid pathology in 3xTg-AD mice. International Journal of Physiology, Pathophysiology and Pharmacology. 4: 115-27. PMID 23071869  0.8
2012 Counts SE, He B, Nadeem M, Wuu J, Scheff SW, Mufson EJ. Hippocampal drebrin loss in mild cognitive impairment. Neuro-Degenerative Diseases. 10: 216-9. PMID 22310934 DOI: 10.1159/000333122  0.8
2012 Perez SE, Getova DP, He B, Counts SE, Geula C, Desire L, Coutadeur S, Peillon H, Ginsberg SD, Mufson EJ. Rac1b increases with progressive tau pathology within cholinergic nucleus basalis neurons in Alzheimer's disease. The American Journal of Pathology. 180: 526-40. PMID 22142809 DOI: 10.1016/j.ajpath.2011.10.027  0.8
2012 Mufson EJ, Binder L, Counts SE, DeKosky ST, de Toledo-Morrell L, Ginsberg SD, Ikonomovic MD, Perez SE, Scheff SW. Mild cognitive impairment: pathology and mechanisms. Acta Neuropathologica. 123: 13-30. PMID 22101321 DOI: 10.1007/s00401-011-0884-1  0.8
2011 Ginsberg SD, Mufson EJ, Alldred MJ, Counts SE, Wuu J, Nixon RA, Che S. Upregulation of select rab GTPases in cholinergic basal forebrain neurons in mild cognitive impairment and Alzheimer's disease. Journal of Chemical Neuroanatomy. 42: 102-10. PMID 21669283 DOI: 10.1016/j.jchemneu.2011.05.012  0.8
2011 Counts SE, Che S, Ginsberg SD, Mufson EJ. Gender differences in neurotrophin and glutamate receptor expression in cholinergic nucleus basalis neurons during the progression of Alzheimer's disease. Journal of Chemical Neuroanatomy. 42: 111-7. PMID 21397006 DOI: 10.1016/j.jchemneu.2011.02.004  0.8
2010 Counts SE, Mufson EJ. PUTATIVE CSF PROTEIN BIOMARKER CANDIDATES FOR AMNESTIC MILD COGNITIVE IMPAIRMENT. Translational Neuroscience. 1: 2-8. PMID 21311725 DOI: 10.2478/v10134-010-0004-0  0.8
2010 Counts SE, Perez SE, Ginsberg SD, Mufson EJ. Neuroprotective role for galanin in Alzheimer's disease. Exs. 102: 143-62. PMID 21299067 DOI: 10.1007/978-3-0346-0228-0_11  0.8
2010 Ginsberg SD, Mufson EJ, Counts SE, Wuu J, Alldred MJ, Nixon RA, Che S. Regional selectivity of rab5 and rab7 protein upregulation in mild cognitive impairment and Alzheimer's disease. Journal of Alzheimer's Disease : Jad. 22: 631-9. PMID 20847427 DOI: 10.3233/JAD-2010-101080  0.8
2010 Ginsberg SD, Alldred MJ, Counts SE, Cataldo AM, Neve RL, Jiang Y, Wuu J, Chao MV, Mufson EJ, Nixon RA, Che S. Microarray analysis of hippocampal CA1 neurons implicates early endosomal dysfunction during Alzheimer's disease progression. Biological Psychiatry. 68: 885-93. PMID 20655510 DOI: 10.1016/j.biopsych.2010.05.030  0.8
2010 Counts SE, Mufson EJ. Noradrenaline activation of neurotrophic pathways protects against neuronal amyloid toxicity. Journal of Neurochemistry. 113: 649-60. PMID 20132474 DOI: 10.1111/j.1471-4159.2010.06622.x  0.8
2010 Mufson EJ, Wuu J, Counts SE, Nykjaer A. Preservation of cortical sortilin protein levels in MCI and Alzheimer's disease. Neuroscience Letters. 471: 129-33. PMID 20085800 DOI: 10.1016/j.neulet.2010.01.023  0.8
2010 Perez SE, Berg BM, Moore KA, He B, Counts SE, Fritz JJ, Hu YS, Lazarov O, Lah JJ, Mufson EJ. DHA diet reduces AD pathology in young APPswe/PS1 Delta E9 transgenic mice: possible gender effects. Journal of Neuroscience Research. 88: 1026-40. PMID 19859965 DOI: 10.1002/jnr.22266  0.8
2009 Counts SE, He B, Che S, Ginsberg SD, Mufson EJ. Galanin fiber hyperinnervation preserves neuroprotective gene expression in cholinergic basal forebrain neurons in Alzheimer's disease. Journal of Alzheimer's Disease : Jad. 18: 885-96. PMID 19749437 DOI: 10.3233/JAD-2009-1196  0.8
2009 Ikonomovic MD, Wecker L, Abrahamson EE, Wuu J, Counts SE, Ginsberg SD, Mufson EJ, Dekosky ST. Cortical alpha7 nicotinic acetylcholine receptor and beta-amyloid levels in early Alzheimer disease. Archives of Neurology. 66: 646-51. PMID 19433665 DOI: 10.1001/archneurol.2009.46  0.8
2008 Mufson EJ, Counts SE, Perez SE, Ginsberg SD. Cholinergic system during the progression of Alzheimer's disease: therapeutic implications. Expert Review of Neurotherapeutics. 8: 1703-18. PMID 18986241 DOI: 10.1586/14737175.8.11.1703  0.8
2008 Counts SE, Perez SE, Mufson EJ. Galanin in Alzheimer's disease: neuroinhibitory or neuroprotective? Cellular and Molecular Life Sciences : Cmls. 65: 1842-53. PMID 18500641 DOI: 10.1007/s00018-008-8159-2  0.8
2008 Counts SE, He B, Che S, Ginsberg SD, Mufson EJ. Galanin hyperinnervation upregulates choline acetyltransferase expression in cholinergic basal forebrain neurons in Alzheimer's disease. Neuro-Degenerative Diseases. 5: 228-31. PMID 18322398 DOI: 10.1159/000113710  0.8
2007 Counts SE, He B, Che S, Ikonomovic MD, DeKosky ST, Ginsberg SD, Mufson EJ. Alpha7 nicotinic receptor up-regulation in cholinergic basal forebrain neurons in Alzheimer disease. Archives of Neurology. 64: 1771-6. PMID 18071042 DOI: 10.1001/archneur.64.12.1771  0.8
2007 Mufson EJ, Counts SE, Fahnestock M, Ginsberg SD. Cholinotrophic molecular substrates of mild cognitive impairment in the elderly. Current Alzheimer Research. 4: 340-50. PMID 17908035 DOI: 10.2174/156720507781788855  0.8
2007 Sortwell CE, Bowers WJ, Counts SE, Pitzer MR, Fleming MF, McGuire SO, Maguire-Zeiss KA, Federoff HJ, Collier TJ. Effects of ex vivo transduction of mesencephalic reaggregates with bcl-2 on grafted dopamine neuron survival. Brain Research. 1134: 33-44. PMID 17196186 DOI: 10.1016/j.brainres.2006.11.079  0.8
2006 Mufson EJ, Counts SE, Che S, Ginsberg SD. Neuronal gene expression profiling: uncovering the molecular biology of neurodegenerative disease. Progress in Brain Research. 158: 197-222. PMID 17027698 DOI: 10.1016/S0079-6123(06)58010-0  0.8
2006 Ginsberg SD, Che S, Counts SE, Mufson EJ. Single cell gene expression profiling in Alzheimer's disease. Neurorx : the Journal of the American Society For Experimental Neurotherapeutics. 3: 302-18. PMID 16815214 DOI: 10.1016/j.nurx.2006.05.007  0.8
2006 Counts SE, Nadeem M, Lad SP, Wuu J, Mufson EJ. Differential expression of synaptic proteins in the frontal and temporal cortex of elderly subjects with mild cognitive impairment. Journal of Neuropathology and Experimental Neurology. 65: 592-601. PMID 16783169 DOI: 10.1097/00005072-200606000-00007  0.8
2006 Ginsberg SD, Che S, Wuu J, Counts SE, Mufson EJ. Down regulation of trk but not p75NTR gene expression in single cholinergic basal forebrain neurons mark the progression of Alzheimer's disease. Journal of Neurochemistry. 97: 475-87. PMID 16539663 DOI: 10.1111/j.1471-4159.2006.03764.x  0.8
2006 Ginsberg SD, Che S, Counts SE, Mufson EJ. Shift in the ratio of three-repeat tau and four-repeat tau mRNAs in individual cholinergic basal forebrain neurons in mild cognitive impairment and Alzheimer's disease. Journal of Neurochemistry. 96: 1401-8. PMID 16478530 DOI: 10.1111/j.1471-4159.2005.03641.x  0.8
2006 Counts SE, Chen EY, Che S, Ikonomovic MD, Wuu J, Ginsberg SD, Dekosky ST, Mufson EJ. Galanin fiber hypertrophy within the cholinergic nucleus basalis during the progression of Alzheimer's disease. Dementia and Geriatric Cognitive Disorders. 21: 205-14. PMID 16410678 DOI: 10.1159/000090906  0.8
2005 Counts SE, Chen EY, Ginsberg SD, Kordower JH, Mufson EJ. RNA amplification of bromodeoxyuridine labeled newborn neurons in the monkey hippocampus. Journal of Neuroscience Methods. 144: 197-201. PMID 15910978 DOI: 10.1016/j.jneumeth.2004.11.005  0.8
2005 Mufson EJ, Counts SE, Perez SE, Binder L. Galanin plasticity in the cholinergic basal forebrain in Alzheimer's disease and transgenic mice. Neuropeptides. 39: 233-7. PMID 15893372 DOI: 10.1016/j.npep.2004.12.005  0.8
2005 He B, Counts SE, Perez SE, Hohmann JG, Koprich JB, Lipton JW, Steiner RA, Crawley JN, Mufson EJ. Ectopic galanin expression and normal galanin receptor 2 and galanin receptor 3 mRNA levels in the forebrain of galanin transgenic mice. Neuroscience. 133: 371-80. PMID 15885921 DOI: 10.1016/j.neuroscience.2005.01.068  0.8
2005 Counts SE, Mufson EJ. The role of nerve growth factor receptors in cholinergic basal forebrain degeneration in prodromal Alzheimer disease. Journal of Neuropathology and Experimental Neurology. 64: 263-72. PMID 15835262  0.8
2004 Counts SE, Nadeem M, Wuu J, Ginsberg SD, Saragovi HU, Mufson EJ. Reduction of cortical TrkA but not p75(NTR) protein in early-stage Alzheimer's disease. Annals of Neurology. 56: 520-31. PMID 15455399 DOI: 10.1002/ana.20233  0.8
2004 Ginsberg SD, Elarova I, Ruben M, Tan F, Counts SE, Eberwine JH, Trojanowski JQ, Hemby SE, Mufson EJ, Che S. Single-cell gene expression analysis: implications for neurodegenerative and neuropsychiatric disorders. Neurochemical Research. 29: 1053-64. PMID 15176463 DOI: 10.1023/B:NERE.0000023593.77052.f7  0.8
2003 Counts SE, Perez SE, Ginsberg SD, De Lacalle S, Mufson EJ. Galanin in Alzheimer disease. Molecular Interventions. 3: 137-56. PMID 14993421 DOI: 10.1124/mi.3.3.137  0.8
2003 Mufson EJ, Ikonomovic MD, Styren SD, Counts SE, Wuu J, Leurgans S, Bennett DA, Cochran EJ, DeKosky ST. Preservation of brain nerve growth factor in mild cognitive impairment and Alzheimer disease. Archives of Neurology. 60: 1143-8. PMID 12925373 DOI: 10.1001/archneur.60.8.1143  0.8
2002 Mufson EJ, Counts SE, Ginsberg SD. Gene expression profiles of cholinergic nucleus basalis neurons in Alzheimer's disease. Neurochemical Research. 27: 1035-48. PMID 12462403 DOI: 10.1023/A:1020952704398  0.8
2002 Counts SE, McGuire SO, Sortwell CE, Crawley JN, Collier TJ, Mufson EJ. Galanin inhibits tyrosine hydroxylase expression in midbrain dopaminergic neurons. Journal of Neurochemistry. 83: 442-51. PMID 12423254 DOI: 10.1046/j.1471-4159.2002.01148.x  0.8
2001 Counts SE, Perez SE, Kahl U, Bartfai T, Bowser RP, Deecher DC, Mash DC, Crawley JN, Mufson EJ. Galanin: neurobiologic mechanisms and therapeutic potential for Alzheimer's disease. Cns Drug Reviews. 7: 445-70. PMID 11830760  0.8
2001 Jaffar S, Counts SE, Ma SY, Dadko E, Gordon MN, Morgan D, Mufson EJ. Neuropathology of mice carrying mutant APP(swe) and/or PS1(M146L) transgenes: alterations in the p75(NTR) cholinergic basal forebrain septohippocampal pathway. Experimental Neurology. 170: 227-43. PMID 11476589 DOI: 10.1006/exnr.2001.7710  0.8
2001 Counts SE, Lah JJ, Levey AI. The regulation of presenilin-1 by nerve growth factor. Journal of Neurochemistry. 76: 679-89. PMID 11158238 DOI: 10.1046/j.1471-4159.2001.00014.x  0.8
1999 Wilson JR, Manning KA, Forestner DM, Counts SE, Uhlrich DJ. Comparison of cholinergic and histaminergic axons in the lateral geniculate complex of the macaque monkey. The Anatomical Record. 255: 295-305. PMID 10411396 DOI: 10.1002/(SICI)1097-0185(19990701)255:3<295::AID-AR5>3.0.CO;2-Q  0.8
1998 Gilmor ML, Counts SE, Wiley RG, Levey AI. Coordinate expression of the vesicular acetylcholine transporter and choline acetyltransferase following septohippocampal pathway lesions. Journal of Neurochemistry. 71: 2411-20. PMID 9832139  0.8
1997 Lah JJ, Heilman CJ, Nash NR, Rees HD, Yi H, Counts SE, Levey AI. Light and electron microscopic localization of presenilin-1 in primate brain. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 17: 1971-80. PMID 9045726  0.8
Show low-probability matches.